Scientific Advisory Board

Stanley Plotkin, M.D.

Dr. Stanley A. Plotkin is Emeritus Professor of the University of Pennsylvania, and Adjunct Professor of the Johns Hopkins University. Until 1991, he was Professor of Pediatrics and Microbiology at the University of Pennsylvania, Professor of Virology at the Wistar Institute, and at the same time, Director of Infectious Diseases and Senior Physician at the Children’s Hospital of Philadelphia. In 1991, Dr. Plotkin left the University to join the vaccine manufacturer, Pasteur-Mérieux-Connaught, where for seven years he was Medical and Scientific Director, based at Marnes-la-Coquette, now known as Sanofi Pasteur.

Dr. Plotkin has developed several pediatric vaccines including the rubella vaccine now in standard use throughout the world and a recently licensed pentavalent rotavirus vaccine. He has also been involved in other vaccine development programs including anthrax, oral polio, rabies, varicella, and cytomegalovirus.

Dr. Plotkin’s bibliography includes nearly 700 articles and he has edited several books including the standard textbook on vaccines, now in its 5th edition. He is a consultant to vaccine manufacturers, biotechnology companies, and non-profit research organizations as principal of Vaxconsult, LLC.

Dr. Plotkin attended New York University, where he received a B.A. degree, and then the State University of New York Medical School in Brooklyn, where he received an M.D. degree in 1956.

Florian Schödel, M.D.

Dr. Florian Schödel has more than 20 years of pharmaceutical, biotech industry, and academic experience leading teams in the development of vaccines and biologics. A physician and microbiologist by training, Dr. Schödel was a VP of Vaccines Clinical Research at Merck Research Laboratories and holds adjunct faculty appointments at the University of Munich and at the Biodesign Center of ASU.

Dr. Schödel’s research at the Max-Planck Institute for Biochemistry, at Scripps, WRAIR, and INSERM focused on novel recombinant vaccines against diseases such as hepatitis B, malaria, and typhoid. He has led the clinical teams responsible for several successful vaccine filings in the U.S., EU and globally, including several pediatric combination vaccines and novel vaccines for different indications.

Dr. Schödel received his degree in medicine from Technical University, Munich, and has earned doctorates in Transplantation Immunology and Medical Microbiology. In the last several years, he has led an international consulting firm that advises companies on pharmaceutical development strategies.

Denis R. Burger, Ph.D.

Dr. Denis Burger is currently on the board of directors of three publicly traded biotechnology companies (Trinity Biotech plc in Dublin, Lorus Therapeutics in Toronto, and CytoDyn in Vancouver) and is currently chairman of AMES Technology, a private medical company.

He was a faculty member at Oregon Health Sciences University for fifteen years starting in 1969 and was Professor of Microbiology and Immunology from 1983-1986. He was a Career Scientist at the Veterans Administration Medical Center in Portland from 1979 to 1986 and has published over 100 manuscripts in medical and scientific journals on the regulation of the immune response.

Dr. Burger received his A.B. degree in Bacteriology and Immunology from the University of California, Berkeley in 1965 and his Ph.D. in Microbiology and Immunology in 1969.